ConductScience.org, home

Paper37573408

FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.

Pawlikowska P and 7 others. Oncogene, 2023. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations. Papers, record 37573408. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37573408

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.
PubMed
Journal
Oncogene
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2023-09-22
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pawlikowska PPatrycja
2Delestré LLaure
3Gregoricchio SSebastianhttps://orcid.org/0000-0001-9209-5403
4Oppezzo AAlessia
5Esposito MMichela
6Diop MBM' Boyba
7Rosselli FFilippohttps://orcid.org/0000-0003-1080-5745
8Guillouf CChristelhttps://orcid.org/0000-0001-7013-3149

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LeukemiaMajor topic
Fanconi Anemia Complementation Group A ProteinMajor topic
Animals
Mice
Heterozygote
Mutation
Oncogenes

Source PubMed

Download CSV of topics

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
232025018The repertoire of mutational signatures in human cancer.Nature2020https://conductscience.org/library/papers/32025018PubMed
333194896DNA Repair Syndromes and Cancer: Insights Into Genetics and Phenotype Patterns.Front Pediatr2020https://conductscience.org/library/papers/33194896PubMed
429617664Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.Cell Rep2018https://conductscience.org/library/papers/29617664PubMed
525999502Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.Science2015https://conductscience.org/library/papers/25999502PubMed
625426837Age-related clonal hematopoiesis associated with adverse outcomes.N Engl J Med2014https://conductscience.org/library/papers/25426837PubMed
712130514Heterozygous PU.1 mutations are associated with acute myeloid leukemia.Blood2002https://conductscience.org/library/papers/12130514PubMed
815146183Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.Nat Genet2004https://conductscience.org/library/papers/15146183PubMed
92827041Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.Nature1988https://conductscience.org/library/papers/2827041PubMed
1031018969A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation.Cancer Discov2019https://conductscience.org/library/papers/31018969PubMed
1128671687Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia.Nat Genet2017https://conductscience.org/library/papers/28671687PubMed
1226343801Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia.Nat Med2015https://conductscience.org/library/papers/26343801PubMed
1334938963KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility.FASEB Bioadv2021https://conductscience.org/library/papers/34938963PubMed
148628313Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.Mol Cell Biol1996https://conductscience.org/library/papers/8628313PubMed
1516338660Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice.Cancer Cell2005https://conductscience.org/library/papers/16338660PubMed
1632350520Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.Blood2020https://conductscience.org/library/papers/32350520PubMed
1733512458Modeling and targeting of erythroleukemia by hematopoietic genome editing.Blood2021https://conductscience.org/library/papers/33512458PubMed
1827094386Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway.Cell Mol Life Sci2016https://conductscience.org/library/papers/27094386PubMed
1932466131The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links.Genes (Basel)2020https://conductscience.org/library/papers/32466131PubMed
2033723374Beyond DNA repair and chromosome instability-Fanconi anaemia as a cellular senescence-associated syndrome.Cell Death Differ2021https://conductscience.org/library/papers/33723374PubMed

See all 51 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
41814545Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.Stem Cells Transl Med2026https://conductscience.org/library/papers/41814545PubMed
41303409Novel Therapeutic Strategy for Renal Cell Carcinoma: Niclosamide Enhances Sunitinib Efficacy via DNA Repair and Cell Cycle Pathways.Int J Mol Sci2025https://conductscience.org/library/papers/41303409PubMed
41155398Beyond Hematologic Malignancies: Colorectal Cancer as a Solid Tumor Manifestation of Inherited Bone Marrow Failure Syndromes.Int J Mol Sci2025https://conductscience.org/library/papers/41155398PubMed
40594369Feasibility of long-read sequencing to identify molecular alterations in an Indonesian cohort of locally advanced to advanced nasopharyngeal cancer.Sci Rep2025https://conductscience.org/library/papers/40594369PubMed
39519198Translational Research on Azacitidine Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2).Int J Mol Sci2024https://conductscience.org/library/papers/39519198PubMed
39375712FANCA promotes lung adenocarcinoma progression and is a potential target for epitope vaccine immunotherapy.J Transl Med2024https://conductscience.org/library/papers/39375712PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37573408

GET https://conductscience.org/api/papers/v1/37573408/references?page=2